| |
| |
|
| Insider
Information: |
Gonyer David A |
| Relationship: |
Director |
| City: |
San Diego |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
341,681 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$187,269 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
341,681 |
|
|
| Total
Value |
$187,269 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
2
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
2
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-2.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -122.1%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Evoke Pharma Inc |
EVOK |
President and CEO, Dir... |
2020-12-14 |
339,782 |
|
0 |
Premium* |
|
|
Viridian Therapeutics Ors Shs |
VRDN |
Director |
2017-02-08 |
1,899 |
2015-07-17 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
16 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| EVOK |
Evoke Pharma Inc |
President and CEO |
• • – |
2020-12-14 |
4 |
S |
$2.94 |
$70,425 |
D/D |
(23,954) |
339,782 |
0 |
% |
|
| EVOK |
Evoke Pharma Inc |
President and CEO |
• • – |
2020-12-11 |
4 |
S |
$2.90 |
$139,333 |
D/D |
(48,046) |
363,736 |
0 |
% |
|
| EVOK |
Evoke Pharma Inc |
President and CEO |
• • – |
2020-12-09 |
4 |
OE |
$0.40 |
$28,800 |
D/D |
72,000 |
411,782 |
0 |
- |
|
| EVOK |
Evoke Pharma Inc |
President and CEO |
• • – |
2020-09-01 |
4 |
A |
$1.05 |
$21,250 |
D/D |
20,238 |
339,782 |
0 |
- |
|
| EVOK |
Evoke Pharma Inc |
President and CEO |
• • – |
2018-08-31 |
4 |
A |
$1.63 |
$11,249 |
D/D |
6,901 |
319,544 |
0 |
- |
|
| EVOK |
Evoke Pharma Inc |
President and CEO |
• • – |
2017-08-31 |
4 |
A |
$2.15 |
$17,716 |
D/D |
8,240 |
312,643 |
0 |
- |
|
| EVOK |
Evoke Pharma Inc |
President and CEO |
• • – |
2017-02-28 |
4 |
A |
$1.60 |
$19,200 |
D/D |
12,000 |
304,403 |
0 |
- |
|
| VRDN |
Viridian Therapeutics Ors... |
Director |
– • – |
2017-02-08 |
4 |
OE |
$7.65 |
$9,180 |
D/D |
1,200 |
1,899 |
0 |
- |
|
| EVOK |
Evoke Pharma Inc |
President and CEO |
• • – |
2016-03-01 |
4 |
A |
$2.90 |
$13,540 |
D/D |
4,669 |
292,403 |
0 |
- |
|
| EVOK |
Evoke Pharma Inc |
President and CEO |
• • – |
2015-08-31 |
4 |
A |
$3.31 |
$13,316 |
D/D |
4,023 |
287,734 |
0 |
- |
|
| VRDN |
Viridian Therapeutics Ors... |
Director |
– • – |
2015-08-06 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
10,500 |
0 |
- |
|
| VRDN |
Viridian Therapeutics Ors... |
Director |
– • – |
2015-08-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,125 |
5,500 |
0 |
- |
|
| VRDN |
Viridian Therapeutics Ors... |
Director |
– • – |
2015-07-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,375 |
1,375 |
0 |
- |
|
| EVOK |
Evoke Pharma Inc |
President and CEO |
• • – |
2015-02-27 |
4 |
A |
$4.75 |
$12,877 |
D/D |
2,711 |
283,711 |
0 |
- |
|
| EVOK |
Evoke Pharma Inc |
President and CEO |
• • – |
2014-03-31 |
5 |
D |
$0.00 |
$0 |
D/D |
(164,000) |
281,000 |
0 |
- |
|
| EVOK |
Evoke Pharma Inc |
President and CEOOfficer |
• • – |
2013-09-24 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
445,000 |
|
- |
|
16 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
